BC Catalyst

BC Catalyst is an AI-native, SaaS-based precision medicine intelligence platform developed by BC Platforms. Designed for pharmaceutical, biotech, and life sciences teams, it combines genomic, clinical, and real-world data with public-domain intelligence to deliver a 360° view of the precision medicine landscape. Built on a proprietary agentic AI model that continuously learns and grows, BC Catalyst supports the entire drug development lifecycle — from early discovery through clinical development, product launch, market access, and post-market activities.

Powered by BC Unify, BC Platforms' integration engine, BC Catalyst ingests, enriches, and harmonises diverse data from 150+ data partners across 35+ countries into a unified structure that supports advanced analytics and healthcare research. The platform features a pharma-grade UX designed specifically for translational pharma teams, enabling fast, confident decision-making without requiring software installation.

Core Modules and Capabilities

• AI-Powered Cohort Composer: Quickly build and query patient cohorts using harmonised genomic and clinical data. Define, filter, and segment populations across disease areas to support research, trial planning, and commercialisation strategies.
• Deep Biomarker Intelligence: Unlock actionable insights into biomarker-drug-response relationships. Accelerate drug discovery, optimise therapy selection, and predict late-stage failures using advanced analytics and visualisations.
• Standard of Care Insights (coming soon): Reveal population-level health trends, real-world outcomes, and evolving standards of care. Visualise patient journeys, treatment patterns, and market opportunities to inform value-based care and commercial strategies.
• Custom Report Builder (coming soon): Create tailored reports by pulling information from all modules within BC Catalyst. AI-supported workflows and visualisations make it easy to share insights across teams in a model that continually learns with use.

Platform Features and User Experience

• Agentic AI Intelligence: Enables intuitive, conversational data exploration for all users through an agentic AI model built specifically for life sciences by domain experts.
• Pharma-Designed UX: Integrates data, compliance, and usability for translational pharma teams to save time, provide peace of mind, and simplify initial analysis.
• Advanced Visualisations: Generates bar charts, pie charts, Sankey diagrams, risk maps, and other visualisation types for easy sharing and further exploration.
• Easy Adoption: Available as a web-based subscription platform requiring no installation, supporting rapid adoption within and across teams.
• Single Unified Platform: Unifies genomics, multi-modal data, public sources, and proprietary agentic AI in one powerful environment covering the full drug lifecycle from discovery to post-market needs.

Use Cases Across the Drug Development Lifecycle

1. Drug Discovery: Biomarker identification, drug target discovery, disease mechanism elucidation, and drug repurposing.
2. Pre-Clinical / Clinical: Trial design optimisation, external control arms, patient stratification, pharmacogenomic analysis, and real-time cohort monitoring.
3. Pre-Launch / Launch: Regulatory submission support, patient recruitment, comparative effectiveness studies, safety signal detection, data harmonisation for trials, patient journey mapping, payer engagement, market positioning, and stakeholder communication.
4. Market Access: HTA submissions, regional market tailoring, cost-effectiveness analysis, predictive modelling, and patient recontact for studies.
5. Post-Launch: Pharmacovigilance, label expansion, treatment optimisation, post-authorisation safety studies (PASS), drug repurposing exploration, and patient-centric outcome tracking.

Strategic Value and Competitive Advantages

• Accelerate Drug Development: Reduce time-to-market through optimised target identification and patient stratification.
• Enhance Commercial Performance: Increase treatment success rates through precision patient matching.
• Mitigate Risks: Minimise late-stage failures and safety concerns through predictive analytics.
• Gain Market Leadership: Establish a competitive advantage in the rapidly expanding precision medicine market.

BC Platforms meets the highest international standards for data protection, product quality, and ethical data governance. ISO-certified systems and compliance frameworks protect every stage of the data lifecycle, ensuring that organisations can innovate confidently and responsibly. BC Catalyst is available via subscription as a web-based platform, making it accessible to a variety of user roles across global organisations.